<DOC>
	<DOCNO>NCT00257751</DOCNO>
	<brief_summary>Clopidogrel ( Plavix ) , platelet ADP receptor antagonist , become standard care prevent thrombosis interventional cardiology increasingly use unstable angina NSTEMI . An increase number patient refer emergent urgent CABG , several study , well experience , show preoperative administration irreversible platelet inhibitor increase risk bleed complication follow CABG .</brief_summary>
	<brief_title>Different Regimen Aprotinine ( Trasylol ) Administration Patients Receiving Antiplatelet Therapy With Clopidogrel ( Plavix )</brief_title>
	<detailed_description>Aprotinine ( Trasylol ) potent antifibrinolytic agent know reduce bleed cardiac surgery . The commeon practice give Trasylol high dos immediately surgery , operation , first postoperative hour . However , also show hemostatic effect drug give low dose postoperatively , remain unclear .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aprotinin</mesh_term>
	<criteria>All coronary bypass operation patient receive Plavix within last 7 day</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>